PubMed · 1993 · 11 citations · 0 references
MedicineImmunologyPharmacotherapyAutoimmunityInflammationRheumatologyAutoimmune DiseasesInflammatory ArthritisJoint DiseaseJoint PathologyRheumatoid ArthritisSynovial InflammationClinical Activity ScoringHistologic ExaminationHistopathology Of SynovitisInflammatory Synovial PathologyNonsteroidal Anti-inflammatory Drug PharmacologyNsaid TherapySynovial Inflammatory InjurySynovial Membrane Histopathology
OBJECTIVE: To study the changes in rheumatoid synovitis induced by the nonsteroidal antiinflammatory drug (NSAID), naproxen, and methotrexate (MTX). METHODS: Twelve patients were treated with naproxen, and 11 with MTX and a clinical activity index was measured before and after treatment. A synovial biopsy was taken, on entry into the study and after 73 +/- 43 days in the NSAID group and 145 +/- 35 in the MTX group. Synovial cells bearing CD3, CD4, CD8, CD19, LeuM5 (CD11c), HLA-DR, HLA-DP and CD25 antigens were measured by stereology. RESULTS: Patients treated with MTX showed a reduction in the number of CD3+ (p = 0.01), CD4+ (p = 0.007) and HLA-DR+ (p = 0.01) cells with an improvement in the activity index (p = 0.001). The patients treated with naproxen did not show changes in the activity index or in the synovial infiltrate. CONCLUSION: Our findings support the theory that clinical improvement in rheumatoid synovitis is associated with a significant decrease in the number of T cells infiltrating the synovial membrane.